[
    {
        "document": "Lucas et al.",
        "metadata": {
            "originalPdf": "Altered circadian behavior and light sensing in mouse models of Alzheimer’s disease’.pdf",
            "originalText": "fnagi-15-1218193 June 14, 2023 Time: 15:21 # 9\nWeigel et al. 10.3389/fnagi.2023.1218193\nFIGURE 5\nIncreased ipRGC density in 3xTg retinas. Thirteen month old WT and 3xTg sagitally sectioned retinas were stained with DAPI and (A)D54D2 for A b,\n(B)pThr231 for phospho-tau, and (C)RBPMS for retinal ganglion cells. (D)Quantiﬁcation of panel (C).(E)Retina whole mounts from WT and 3xTg\nmice stained for melanopsin to identify ipRGCs. (F)Quantiﬁcation of panel (E). All analyses are two tailed Student’s t-tests. All data plotted as\nmean \u0006SEM. Scale bars = 50 mm.\n(Kiessling et al., 2010). Total running distance and preference for\nrunning in the dark were measured after all mice had completely\nre-entrained after a phase shift and were averaged across 2 days.\nTo determine free running period, after all mice had completely re-\nentrained they were switched to DD and period was calculated from\nthe onset of activity across 7 days.\nIn masking trials, light intensity was decreased by wrapping\nﬂuorescent lights in neutral density ﬁlter ﬁlms and measured witha spectrometer (Sekonic Spectrometer C-800). Illuminance was\nmeasured in lux, and photon ﬂux, summed from 380 to 780 nm,\nwas calculated using formulas in the supplementary materials in\nLucas et al. (2014). A 1hr light pulse was delivered from ZT13-\n14. Percent running in light was calculated by comparing to the\nactivity measured during the same period of constant darkness on\nthe preceding day for each mouse. Individual trials were separated\nfrom each other by 3–4 days.\nFrontiers in Aging Neuroscience 09 frontiersin.org",
            "page": 8
        },
        "id": "650"
    },
    {
        "document": "Lucas et al.",
        "metadata": {
            "originalPdf": "Long wavelength light reduces the negative consequences of dim light at night in the Cntnap2 mouse model of autism.pdf",
            "originalText": "Nightly light exposure is a common environmental perturbation and has been shown to \ncause a number of ill effects (Lucassen et al., 2016; Bumgarner et al., 2021) . Some populations \nmay be more vulnerable to the negative effects of the exposure of light at night.  For exam ple, in \nthe Cntnap2  KO mouse model of ASD, we have found that DLaN selectively increases repetitive \nbehavior as measured by grooming  while  WT mice were not impacted (Wang et al., 2020).  On \nthe other hand, DLaN negatively impacted other behaviors including social interactions and \ndaily activity rhythms  in both the Cntnap2 KO and WT mice.  In the present study, we confirmed \nthese negative eff ects of nocturnal lighting on activity rhythms, social interactions, and repetitive \nbehaviors ( Table 3). Logically, the simplest approach to reducing these negative effects would \nsolely be to decrease light intensity at night while ensuring a robust exposure to sunlight during \nthe day.  However, according to surveys, people spend a majority of time indoors (as high as \n90%) and have need for illumination after the sun sets  (e.g. Klepeis et  al., 2001) . Therefore an \nappealing alternative approach would be to adjust the spectral quality of indoor lighting to \nminimize the negative effects.  As a test case, in the present study, we used an array of LEDs to \ngenerate dim illumination (10 lx) to determine whether the spectral composition of nightly \nillumination would make a difference in the Cntnap2 KO model of autism.   \nThe retinal photoreceptor system has unique intensity and wavelength dependent \ncharacteristics (Lucas et al., 2014) . The negative effects of nightly light exposure are likely to be \nmediated by ipRGCs  expressing the photopigment melanopsin, which is maximally sensitive to \nlight with a peak response to ≈480nm light (Hattar et al., 2002; Panda et al., 2005). Indeed a \nnumber of studies have found evidence that short λ enriched lighting is more effective for \ncircadian responses ( for review see Brown, 2020).  However, recent work emphasizes that \nipRGCs also receive input from rod and cone photoreceptors (Hattar et al., 2003; Lucas et al., \n2012; Van Diepen et al., 2021; Schoonderwoerd et al., 2022) with rods driving the circadian \nresponse to low -intensity light (Altimus et al., 2010; Lall et al 2010)  like the 10 lx used in the \npresent study.  Here w e used an LED lighting system (Korrus Inc. ) to tailor the spectral \nproperties of the DLaN with the goal of manipulat ing melanopic  stimulation.  The output of the \nLEDs was measured as power over a defined wavelength (380 -780nm) using a \nspectrophotometer. This data was analysed using a C IE toolkit  which enabled us to estimate \nthat the s hort λ illumination was at 15 melanopic lx while the long λ illumination was 1 melanopic \nlx while maintaining illuminance at ≈ 10 lx .   \nUsing these two lighting treatments  with predicted high and low melanopic stimulation, \nwe measured the impact of the illumination on three classic tests of the ipRGC input to the \ncircadian system  (Fig. 1 ). We demonstrated that the low melanopic stimulation reduced the . CC-BY-ND 4.0 International license available under a(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprint this version posted June 12, 2022. ; https://doi.org/10.1101/2022.06.09.494760doi: bioRxiv preprint ",
            "page": 13
        },
        "id": "1840"
    },
    {
        "document": "Altimus et al.",
        "metadata": {
            "originalPdf": "Long wavelength light reduces the negative consequences of dim light at night in the Cntnap2 mouse model of autism.pdf",
            "originalText": "Nightly light exposure is a common environmental perturbation and has been shown to \ncause a number of ill effects (Lucassen et al., 2016; Bumgarner et al., 2021) . Some populations \nmay be more vulnerable to the negative effects of the exposure of light at night.  For exam ple, in \nthe Cntnap2  KO mouse model of ASD, we have found that DLaN selectively increases repetitive \nbehavior as measured by grooming  while  WT mice were not impacted (Wang et al., 2020).  On \nthe other hand, DLaN negatively impacted other behaviors including social interactions and \ndaily activity rhythms  in both the Cntnap2 KO and WT mice.  In the present study, we confirmed \nthese negative eff ects of nocturnal lighting on activity rhythms, social interactions, and repetitive \nbehaviors ( Table 3). Logically, the simplest approach to reducing these negative effects would \nsolely be to decrease light intensity at night while ensuring a robust exposure to sunlight during \nthe day.  However, according to surveys, people spend a majority of time indoors (as high as \n90%) and have need for illumination after the sun sets  (e.g. Klepeis et  al., 2001) . Therefore an \nappealing alternative approach would be to adjust the spectral quality of indoor lighting to \nminimize the negative effects.  As a test case, in the present study, we used an array of LEDs to \ngenerate dim illumination (10 lx) to determine whether the spectral composition of nightly \nillumination would make a difference in the Cntnap2 KO model of autism.   \nThe retinal photoreceptor system has unique intensity and wavelength dependent \ncharacteristics (Lucas et al., 2014) . The negative effects of nightly light exposure are likely to be \nmediated by ipRGCs  expressing the photopigment melanopsin, which is maximally sensitive to \nlight with a peak response to ≈480nm light (Hattar et al., 2002; Panda et al., 2005). Indeed a \nnumber of studies have found evidence that short λ enriched lighting is more effective for \ncircadian responses ( for review see Brown, 2020).  However, recent work emphasizes that \nipRGCs also receive input from rod and cone photoreceptors (Hattar et al., 2003; Lucas et al., \n2012; Van Diepen et al., 2021; Schoonderwoerd et al., 2022) with rods driving the circadian \nresponse to low -intensity light (Altimus et al., 2010; Lall et al 2010)  like the 10 lx used in the \npresent study.  Here w e used an LED lighting system (Korrus Inc. ) to tailor the spectral \nproperties of the DLaN with the goal of manipulat ing melanopic  stimulation.  The output of the \nLEDs was measured as power over a defined wavelength (380 -780nm) using a \nspectrophotometer. This data was analysed using a C IE toolkit  which enabled us to estimate \nthat the s hort λ illumination was at 15 melanopic lx while the long λ illumination was 1 melanopic \nlx while maintaining illuminance at ≈ 10 lx .   \nUsing these two lighting treatments  with predicted high and low melanopic stimulation, \nwe measured the impact of the illumination on three classic tests of the ipRGC input to the \ncircadian system  (Fig. 1 ). We demonstrated that the low melanopic stimulation reduced the . CC-BY-ND 4.0 International license available under a(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprint this version posted June 12, 2022. ; https://doi.org/10.1101/2022.06.09.494760doi: bioRxiv preprint ",
            "page": 13
        },
        "id": "1844"
    },
    {
        "document": "A.Manjavacas",
        "metadata": {
            "originalPdf": "10c5984f-d755-4b18-be0b-84d66e2cdd8a.pdf",
            "originalText": "A.Atwater,A.Polman, Nat.Mater. 2010,9,205.\n[6] J.Langer,D.JimenezDeAberasturi,J.Aizpurua,R.A.Alvarez-Puebla,\nB. Auguié, J. J. Baumberg, G. C. Bazan, S. E. J. Bell, A. Boisen, A. G.\nBrolo, J. Choo, D. Cialla-May, V. Deckert, L. Fabris, K. Faulds, F. J.\nGarcíaDeAbajo,R.Goodacre,D.Graham,A.J.Haes,C.L.Haynes,\nC. Huck, T. Itoh, M. Käll, J. Kneipp, N. A. Kotov, H. Kuang, E. C. Le\nRu,H.K.Lee,J.-F.Li,X.Y.Ling,etal., ACSNano 2020,14,28.\n[7] B. Sharma, R. R. Frontiera, A.-I. Henry, E. Ringe, R. P. Van Duyne,\nMater.Today 2012,15,16.\n[8] N. Liu, M. Mesch, T. Weiss, M. Hentschel, H. Giessen, Nano Lett.\n2010,10,2342.\n[9] J. N. Anker, W. P. Hall, O. Lyandres, N. C. Shah, J. Zhao, R. P. Van\nDuyne,Nat.Mater. 2008,7,442.\n[10] K. C. Bantz, A. F. Meyer, N. J. Wittenberg, H. Im, Ö. Kurtulus, S. H.\nLee,N.C.Lindquist,S.-H.Oh,C.L.Haynes, Phys.Chem.Chem.Phys.\n2011,13,11551.\n[11] R.Bardhan,S.Lal,A.Joshi,N.J.Halas, Acc.Chem.Res. 2011,44,936.\n[12] O. Neumann, A. S. Urban, J. Day, S. Lal, P. Nordlander, N. J. Halas,\nACSNano 2013,7,42.\n[13] J.G.Smith,J.A.Faucheaux,P.K.Jain, NanoToday 2015,10,67.\n[14] L. Zhou, Y. Tan, J. Wang, W. Xu, Y. Yuan, W. Cai, S. Zhu, J. Zhu, Nat.\nPhotonics2016,10,393.\n[15] S.Linic,P.Christopher,D.B.Ingram, Nat.Mater. 2011,10,911.\n[16] Z. Zheng, W. Xie, B. Huang, Y. Dai, Chem., A Eur. J. 2018,24,\n18322.\n[17] P. R. West, S. Ishii, G. V. Naik, N. K. Emani, V. M. Shalaev, A.\nBoltasseva, LaserPhoton.Rev. 2010,4,795.\n[18] G.V.Naik,V.M.Shalaev,A.Boltasseva, Adv.Mater. 2013,25,3264.\n[19] W.A.Murray,W.L.Barnes, Adv.Mater. 2007,19,3771.\n[20] Y.Cui,A.Lauchner,A.Manjavacas,F.J.GarcíaDeAbajo,N.J.Halas,\nP.Nordlander, NanoLett. 2016,16,6390.\n[21] A.Lauchner,A.E.Schlather,A.Manjavacas,Y.Cui,M.J.Mcclain,G.\nJ. Stec, F. J. García De Abajo, P. Nordlander, N. J. Halas, Nano Lett.\n2015,15,6208.\n[22] T.-C.Hung,B.Kiraly,J.H.Strik,A.A.Khajetoorians,D.Wegner, Nano\nLett.20",
            "page": 11
        },
        "id": "2317"
    },
    {
        "document": "A.Manjavacas",
        "metadata": {
            "originalPdf": "10c5984f-d755-4b18-be0b-84d66e2cdd8a.pdf",
            "originalText": "A.Atwater,A.Polman, Nat.Mater. 2010,9,205.\n[6] J.Langer,D.JimenezDeAberasturi,J.Aizpurua,R.A.Alvarez-Puebla,\nB. Auguié, J. J. Baumberg, G. C. Bazan, S. E. J. Bell, A. Boisen, A. G.\nBrolo, J. Choo, D. Cialla-May, V. Deckert, L. Fabris, K. Faulds, F. J.\nGarcíaDeAbajo,R.Goodacre,D.Graham,A.J.Haes,C.L.Haynes,\nC. Huck, T. Itoh, M. Käll, J. Kneipp, N. A. Kotov, H. Kuang, E. C. Le\nRu,H.K.Lee,J.-F.Li,X.Y.Ling,etal., ACSNano 2020,14,28.\n[7] B. Sharma, R. R. Frontiera, A.-I. Henry, E. Ringe, R. P. Van Duyne,\nMater.Today 2012,15,16.\n[8] N. Liu, M. Mesch, T. Weiss, M. Hentschel, H. Giessen, Nano Lett.\n2010,10,2342.\n[9] J. N. Anker, W. P. Hall, O. Lyandres, N. C. Shah, J. Zhao, R. P. Van\nDuyne,Nat.Mater. 2008,7,442.\n[10] K. C. Bantz, A. F. Meyer, N. J. Wittenberg, H. Im, Ö. Kurtulus, S. H.\nLee,N.C.Lindquist,S.-H.Oh,C.L.Haynes, Phys.Chem.Chem.Phys.\n2011,13,11551.\n[11] R.Bardhan,S.Lal,A.Joshi,N.J.Halas, Acc.Chem.Res. 2011,44,936.\n[12] O. Neumann, A. S. Urban, J. Day, S. Lal, P. Nordlander, N. J. Halas,\nACSNano 2013,7,42.\n[13] J.G.Smith,J.A.Faucheaux,P.K.Jain, NanoToday 2015,10,67.\n[14] L. Zhou, Y. Tan, J. Wang, W. Xu, Y. Yuan, W. Cai, S. Zhu, J. Zhu, Nat.\nPhotonics2016,10,393.\n[15] S.Linic,P.Christopher,D.B.Ingram, Nat.Mater. 2011,10,911.\n[16] Z. Zheng, W. Xie, B. Huang, Y. Dai, Chem., A Eur. J. 2018,24,\n18322.\n[17] P. R. West, S. Ishii, G. V. Naik, N. K. Emani, V. M. Shalaev, A.\nBoltasseva, LaserPhoton.Rev. 2010,4,795.\n[18] G.V.Naik,V.M.Shalaev,A.Boltasseva, Adv.Mater. 2013,25,3264.\n[19] W.A.Murray,W.L.Barnes, Adv.Mater. 2007,19,3771.\n[20] Y.Cui,A.Lauchner,A.Manjavacas,F.J.GarcíaDeAbajo,N.J.Halas,\nP.Nordlander, NanoLett. 2016,16,6390.\n[21] A.Lauchner,A.E.Schlather,A.Manjavacas,Y.Cui,M.J.Mcclain,G.\nJ. Stec, F. J. García De Abajo, P. Nordlander, N. J. Halas, Nano Lett.\n2015,15,6208.\n[22] T.-C.Hung,B.Kiraly,J.H.Strik,A.A.Khajetoorians,D.Wegner, Nano\nLett.20",
            "page": 11
        },
        "id": "2327"
    },
    {
        "document": "A.Santos",
        "metadata": {
            "originalPdf": "10c5984f-d755-4b18-be0b-84d66e2cdd8a.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "2387"
    },
    {
        "document": "L.B.Alemany",
        "metadata": {
            "originalPdf": "10c5984f-d755-4b18-be0b-84d66e2cdd8a.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "2397"
    },
    {
        "document": "Guissoni Campos LM",
        "metadata": {
            "originalPdf": "4a98b445-1f09-4a39-8425-dd23b7140e64.pdf",
            "originalText": "/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun 2011; 25(4): 767-76.  [http://dx.doi.org/10.1016/j.bbi.2011.02.002] [PMID: 21333736] [150] Malow BA, McGrew SG. Sleep and quality of life in autism.Sleep and quality of life in medical illness 2008; 221-7.  [http://dx.doi.org/10.1007/978-1-60327-343-5_24] [151] Johnson CR, Smith T, DeMand A, et al. Exploring sleep quality of young children with autism spectrum disorder and disruptive be-haviors. Sleep Med 2018; 44: 61-6.  [http://dx.doi.org/10.1016/j.sleep.2018.01.008] [PMID: 29530371] [152] Turygin N, Matson JL, Tureck K. ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay. Res Dev Disabil 2013; 34(11): 4203-9.  [http://dx.doi.org/10.1016/j.ridd.2013.07.020] [PMID: 24077069] [153] da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin rhythm in Autism: correlation with TNF and sleep disturbances submitted [154] Muscatello RA, Corbett BA. Comparing the effects of age, pubertal development, and symptom profile on cortisol rhythm in children and adolescents with autism spectrum disorder. Autism Res 2018; 11(1): 110-20.  [http://dx.doi.org/10.1002/aur.1879] [PMID: 29030905] [155] Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013; 14(10): 20508-42.  [http://dx.doi.org/10.3390/ijms141020508] [PMID: 24129182] [156] Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief re-port: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25(6): 641-54.  [http://dx.doi.org/10.1007/BF02178193] [PMID: 8720032] [157] Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32(5): 585-9.  [http://dx.doi.org/10.1111/j.1365-2214.2006.00616.x] [PMID: 16919138] [158] Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27(3): 254-89.  [http://dx.doi.org/10.1016/j.ridd.2005.03.003] [PMID: 16002261] [159] Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21(1): 31-4.  [PMID: 11455326] [160] Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low ma-ternal melatonin level increases autism spectrum disorder risk in children. Res Dev Disabil 2018; 82: 79-89.  [http://dx.doi.org/10.1016/j.ridd.2018.02.017] [PMID: 29501372] [161] Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011; 53(9): 783-92.  [http://dx.doi.org/10.1111/j.1469-8749.2011.03980.x] [PMID: 21518346] [162] Johansson AEE, Dorman",
            "page": 13
        },
        "id": "3512"
    },
    {
        "document": "Da Silveira Cruz-Machado S",
        "metadata": {
            "originalPdf": "4a98b445-1f09-4a39-8425-dd23b7140e64.pdf",
            "originalText": "/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun 2011; 25(4): 767-76.  [http://dx.doi.org/10.1016/j.bbi.2011.02.002] [PMID: 21333736] [150] Malow BA, McGrew SG. Sleep and quality of life in autism.Sleep and quality of life in medical illness 2008; 221-7.  [http://dx.doi.org/10.1007/978-1-60327-343-5_24] [151] Johnson CR, Smith T, DeMand A, et al. Exploring sleep quality of young children with autism spectrum disorder and disruptive be-haviors. Sleep Med 2018; 44: 61-6.  [http://dx.doi.org/10.1016/j.sleep.2018.01.008] [PMID: 29530371] [152] Turygin N, Matson JL, Tureck K. ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay. Res Dev Disabil 2013; 34(11): 4203-9.  [http://dx.doi.org/10.1016/j.ridd.2013.07.020] [PMID: 24077069] [153] da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin rhythm in Autism: correlation with TNF and sleep disturbances submitted [154] Muscatello RA, Corbett BA. Comparing the effects of age, pubertal development, and symptom profile on cortisol rhythm in children and adolescents with autism spectrum disorder. Autism Res 2018; 11(1): 110-20.  [http://dx.doi.org/10.1002/aur.1879] [PMID: 29030905] [155] Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013; 14(10): 20508-42.  [http://dx.doi.org/10.3390/ijms141020508] [PMID: 24129182] [156] Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief re-port: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25(6): 641-54.  [http://dx.doi.org/10.1007/BF02178193] [PMID: 8720032] [157] Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32(5): 585-9.  [http://dx.doi.org/10.1111/j.1365-2214.2006.00616.x] [PMID: 16919138] [158] Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27(3): 254-89.  [http://dx.doi.org/10.1016/j.ridd.2005.03.003] [PMID: 16002261] [159] Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21(1): 31-4.  [PMID: 11455326] [160] Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low ma-ternal melatonin level increases autism spectrum disorder risk in children. Res Dev Disabil 2018; 82: 79-89.  [http://dx.doi.org/10.1016/j.ridd.2018.02.017] [PMID: 29501372] [161] Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011; 53(9): 783-92.  [http://dx.doi.org/10.1111/j.1469-8749.2011.03980.x] [PMID: 21518346] [162] Johansson AEE, Dorman",
            "page": 13
        },
        "id": "3516"
    },
    {
        "document": "Campos LM",
        "metadata": {
            "originalPdf": "4a98b445-1f09-4a39-8425-dd23b7140e64.pdf",
            "originalText": "/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun 2011; 25(4): 767-76.  [http://dx.doi.org/10.1016/j.bbi.2011.02.002] [PMID: 21333736] [150] Malow BA, McGrew SG. Sleep and quality of life in autism.Sleep and quality of life in medical illness 2008; 221-7.  [http://dx.doi.org/10.1007/978-1-60327-343-5_24] [151] Johnson CR, Smith T, DeMand A, et al. Exploring sleep quality of young children with autism spectrum disorder and disruptive be-haviors. Sleep Med 2018; 44: 61-6.  [http://dx.doi.org/10.1016/j.sleep.2018.01.008] [PMID: 29530371] [152] Turygin N, Matson JL, Tureck K. ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay. Res Dev Disabil 2013; 34(11): 4203-9.  [http://dx.doi.org/10.1016/j.ridd.2013.07.020] [PMID: 24077069] [153] da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin rhythm in Autism: correlation with TNF and sleep disturbances submitted [154] Muscatello RA, Corbett BA. Comparing the effects of age, pubertal development, and symptom profile on cortisol rhythm in children and adolescents with autism spectrum disorder. Autism Res 2018; 11(1): 110-20.  [http://dx.doi.org/10.1002/aur.1879] [PMID: 29030905] [155] Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013; 14(10): 20508-42.  [http://dx.doi.org/10.3390/ijms141020508] [PMID: 24129182] [156] Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief re-port: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25(6): 641-54.  [http://dx.doi.org/10.1007/BF02178193] [PMID: 8720032] [157] Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32(5): 585-9.  [http://dx.doi.org/10.1111/j.1365-2214.2006.00616.x] [PMID: 16919138] [158] Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27(3): 254-89.  [http://dx.doi.org/10.1016/j.ridd.2005.03.003] [PMID: 16002261] [159] Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21(1): 31-4.  [PMID: 11455326] [160] Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low ma-ternal melatonin level increases autism spectrum disorder risk in children. Res Dev Disabil 2018; 82: 79-89.  [http://dx.doi.org/10.1016/j.ridd.2018.02.017] [PMID: 29501372] [161] Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011; 53(9): 783-92.  [http://dx.doi.org/10.1111/j.1469-8749.2011.03980.x] [PMID: 21518346] [162] Johansson AEE, Dorman",
            "page": 13
        },
        "id": "3541"
    },
    {
        "document": "da Silveira Cruz-Machado S",
        "metadata": {
            "originalPdf": "4a98b445-1f09-4a39-8425-dd23b7140e64.pdf",
            "originalText": "/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun 2011; 25(4): 767-76.  [http://dx.doi.org/10.1016/j.bbi.2011.02.002] [PMID: 21333736] [150] Malow BA, McGrew SG. Sleep and quality of life in autism.Sleep and quality of life in medical illness 2008; 221-7.  [http://dx.doi.org/10.1007/978-1-60327-343-5_24] [151] Johnson CR, Smith T, DeMand A, et al. Exploring sleep quality of young children with autism spectrum disorder and disruptive be-haviors. Sleep Med 2018; 44: 61-6.  [http://dx.doi.org/10.1016/j.sleep.2018.01.008] [PMID: 29530371] [152] Turygin N, Matson JL, Tureck K. ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay. Res Dev Disabil 2013; 34(11): 4203-9.  [http://dx.doi.org/10.1016/j.ridd.2013.07.020] [PMID: 24077069] [153] da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin rhythm in Autism: correlation with TNF and sleep disturbances submitted [154] Muscatello RA, Corbett BA. Comparing the effects of age, pubertal development, and symptom profile on cortisol rhythm in children and adolescents with autism spectrum disorder. Autism Res 2018; 11(1): 110-20.  [http://dx.doi.org/10.1002/aur.1879] [PMID: 29030905] [155] Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013; 14(10): 20508-42.  [http://dx.doi.org/10.3390/ijms141020508] [PMID: 24129182] [156] Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief re-port: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25(6): 641-54.  [http://dx.doi.org/10.1007/BF02178193] [PMID: 8720032] [157] Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32(5): 585-9.  [http://dx.doi.org/10.1111/j.1365-2214.2006.00616.x] [PMID: 16919138] [158] Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27(3): 254-89.  [http://dx.doi.org/10.1016/j.ridd.2005.03.003] [PMID: 16002261] [159] Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21(1): 31-4.  [PMID: 11455326] [160] Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low ma-ternal melatonin level increases autism spectrum disorder risk in children. Res Dev Disabil 2018; 82: 79-89.  [http://dx.doi.org/10.1016/j.ridd.2018.02.017] [PMID: 29501372] [161] Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011; 53(9): 783-92.  [http://dx.doi.org/10.1111/j.1469-8749.2011.03980.x] [PMID: 21518346] [162] Johansson AEE, Dorman",
            "page": 13
        },
        "id": "3545"
    },
    {
        "document": "Guissoni Campos LM",
        "metadata": {
            "originalPdf": "4a98b445-1f09-4a39-8425-dd23b7140e64.pdf",
            "originalText": "/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun 2011; 25(4): 767-76.  [http://dx.doi.org/10.1016/j.bbi.2011.02.002] [PMID: 21333736] [150] Malow BA, McGrew SG. Sleep and quality of life in autism.Sleep and quality of life in medical illness 2008; 221-7.  [http://dx.doi.org/10.1007/978-1-60327-343-5_24] [151] Johnson CR, Smith T, DeMand A, et al. Exploring sleep quality of young children with autism spectrum disorder and disruptive be-haviors. Sleep Med 2018; 44: 61-6.  [http://dx.doi.org/10.1016/j.sleep.2018.01.008] [PMID: 29530371] [152] Turygin N, Matson JL, Tureck K. ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay. Res Dev Disabil 2013; 34(11): 4203-9.  [http://dx.doi.org/10.1016/j.ridd.2013.07.020] [PMID: 24077069] [153] da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin rhythm in Autism: correlation with TNF and sleep disturbances submitted [154] Muscatello RA, Corbett BA. Comparing the effects of age, pubertal development, and symptom profile on cortisol rhythm in children and adolescents with autism spectrum disorder. Autism Res 2018; 11(1): 110-20.  [http://dx.doi.org/10.1002/aur.1879] [PMID: 29030905] [155] Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013; 14(10): 20508-42.  [http://dx.doi.org/10.3390/ijms141020508] [PMID: 24129182] [156] Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief re-port: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25(6): 641-54.  [http://dx.doi.org/10.1007/BF02178193] [PMID: 8720032] [157] Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32(5): 585-9.  [http://dx.doi.org/10.1111/j.1365-2214.2006.00616.x] [PMID: 16919138] [158] Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27(3): 254-89.  [http://dx.doi.org/10.1016/j.ridd.2005.03.003] [PMID: 16002261] [159] Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21(1): 31-4.  [PMID: 11455326] [160] Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low ma-ternal melatonin level increases autism spectrum disorder risk in children. Res Dev Disabil 2018; 82: 79-89.  [http://dx.doi.org/10.1016/j.ridd.2018.02.017] [PMID: 29501372] [161] Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011; 53(9): 783-92.  [http://dx.doi.org/10.1111/j.1469-8749.2011.03980.x] [PMID: 21518346] [162] Johansson AEE, Dorman",
            "page": 13
        },
        "id": "3546"
    },
    {
        "document": "Lucas et al.",
        "metadata": {
            "originalPdf": "2adc961c-6913-45a2-bce5-5fd8aa504ffa.pdf",
            "originalText": "fnagi-15-1218193 June 14, 2023 Time: 15:21 # 9\nWeigel et al. 10.3389/fnagi.2023.1218193\nFIGURE 5\nIncreased ipRGC density in 3xTg retinas. Thirteen month old WT and 3xTg sagitally sectioned retinas were stained with DAPI and (A)D54D2 for A b,\n(B)pThr231 for phospho-tau, and (C)RBPMS for retinal ganglion cells. (D)Quantiﬁcation of panel (C).(E)Retina whole mounts from WT and 3xTg\nmice stained for melanopsin to identify ipRGCs. (F)Quantiﬁcation of panel (E). All analyses are two tailed Student’s t-tests. All data plotted as\nmean \u0006SEM. Scale bars = 50 mm.\n(Kiessling et al., 2010). Total running distance and preference for\nrunning in the dark were measured after all mice had completely\nre-entrained after a phase shift and were averaged across 2 days.\nTo determine free running period, after all mice had completely re-\nentrained they were switched to DD and period was calculated from\nthe onset of activity across 7 days.\nIn masking trials, light intensity was decreased by wrapping\nﬂuorescent lights in neutral density ﬁlter ﬁlms and measured witha spectrometer (Sekonic Spectrometer C-800). Illuminance was\nmeasured in lux, and photon ﬂux, summed from 380 to 780 nm,\nwas calculated using formulas in the supplementary materials in\nLucas et al. (2014). A 1hr light pulse was delivered from ZT13-\n14. Percent running in light was calculated by comparing to the\nactivity measured during the same period of constant darkness on\nthe preceding day for each mouse. Individual trials were separated\nfrom each other by 3–4 days.\nFrontiers in Aging Neuroscience 09 frontiersin.org",
            "page": 8
        },
        "id": "3876"
    },
    {
        "document": "A.Manjavacas",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "A.Atwater,A.Polman, Nat.Mater. 2010,9,205.\n[6] J.Langer,D.JimenezDeAberasturi,J.Aizpurua,R.A.Alvarez-Puebla,\nB. Auguié, J. J. Baumberg, G. C. Bazan, S. E. J. Bell, A. Boisen, A. G.\nBrolo, J. Choo, D. Cialla-May, V. Deckert, L. Fabris, K. Faulds, F. J.\nGarcíaDeAbajo,R.Goodacre,D.Graham,A.J.Haes,C.L.Haynes,\nC. Huck, T. Itoh, M. Käll, J. Kneipp, N. A. Kotov, H. Kuang, E. C. Le\nRu,H.K.Lee,J.-F.Li,X.Y.Ling,etal., ACSNano 2020,14,28.\n[7] B. Sharma, R. R. Frontiera, A.-I. Henry, E. Ringe, R. P. Van Duyne,\nMater.Today 2012,15,16.\n[8] N. Liu, M. Mesch, T. Weiss, M. Hentschel, H. Giessen, Nano Lett.\n2010,10,2342.\n[9] J. N. Anker, W. P. Hall, O. Lyandres, N. C. Shah, J. Zhao, R. P. Van\nDuyne,Nat.Mater. 2008,7,442.\n[10] K. C. Bantz, A. F. Meyer, N. J. Wittenberg, H. Im, Ö. Kurtulus, S. H.\nLee,N.C.Lindquist,S.-H.Oh,C.L.Haynes, Phys.Chem.Chem.Phys.\n2011,13,11551.\n[11] R.Bardhan,S.Lal,A.Joshi,N.J.Halas, Acc.Chem.Res. 2011,44,936.\n[12] O. Neumann, A. S. Urban, J. Day, S. Lal, P. Nordlander, N. J. Halas,\nACSNano 2013,7,42.\n[13] J.G.Smith,J.A.Faucheaux,P.K.Jain, NanoToday 2015,10,67.\n[14] L. Zhou, Y. Tan, J. Wang, W. Xu, Y. Yuan, W. Cai, S. Zhu, J. Zhu, Nat.\nPhotonics2016,10,393.\n[15] S.Linic,P.Christopher,D.B.Ingram, Nat.Mater. 2011,10,911.\n[16] Z. Zheng, W. Xie, B. Huang, Y. Dai, Chem., A Eur. J. 2018,24,\n18322.\n[17] P. R. West, S. Ishii, G. V. Naik, N. K. Emani, V. M. Shalaev, A.\nBoltasseva, LaserPhoton.Rev. 2010,4,795.\n[18] G.V.Naik,V.M.Shalaev,A.Boltasseva, Adv.Mater. 2013,25,3264.\n[19] W.A.Murray,W.L.Barnes, Adv.Mater. 2007,19,3771.\n[20] Y.Cui,A.Lauchner,A.Manjavacas,F.J.GarcíaDeAbajo,N.J.Halas,\nP.Nordlander, NanoLett. 2016,16,6390.\n[21] A.Lauchner,A.E.Schlather,A.Manjavacas,Y.Cui,M.J.Mcclain,G.\nJ. Stec, F. J. García De Abajo, P. Nordlander, N. J. Halas, Nano Lett.\n2015,15,6208.\n[22] T.-C.Hung,B.Kiraly,J.H.Strik,A.A.Khajetoorians,D.Wegner, Nano\nLett.20",
            "page": 11
        },
        "id": "4124"
    },
    {
        "document": "A.Manjavacas",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "A.Atwater,A.Polman, Nat.Mater. 2010,9,205.\n[6] J.Langer,D.JimenezDeAberasturi,J.Aizpurua,R.A.Alvarez-Puebla,\nB. Auguié, J. J. Baumberg, G. C. Bazan, S. E. J. Bell, A. Boisen, A. G.\nBrolo, J. Choo, D. Cialla-May, V. Deckert, L. Fabris, K. Faulds, F. J.\nGarcíaDeAbajo,R.Goodacre,D.Graham,A.J.Haes,C.L.Haynes,\nC. Huck, T. Itoh, M. Käll, J. Kneipp, N. A. Kotov, H. Kuang, E. C. Le\nRu,H.K.Lee,J.-F.Li,X.Y.Ling,etal., ACSNano 2020,14,28.\n[7] B. Sharma, R. R. Frontiera, A.-I. Henry, E. Ringe, R. P. Van Duyne,\nMater.Today 2012,15,16.\n[8] N. Liu, M. Mesch, T. Weiss, M. Hentschel, H. Giessen, Nano Lett.\n2010,10,2342.\n[9] J. N. Anker, W. P. Hall, O. Lyandres, N. C. Shah, J. Zhao, R. P. Van\nDuyne,Nat.Mater. 2008,7,442.\n[10] K. C. Bantz, A. F. Meyer, N. J. Wittenberg, H. Im, Ö. Kurtulus, S. H.\nLee,N.C.Lindquist,S.-H.Oh,C.L.Haynes, Phys.Chem.Chem.Phys.\n2011,13,11551.\n[11] R.Bardhan,S.Lal,A.Joshi,N.J.Halas, Acc.Chem.Res. 2011,44,936.\n[12] O. Neumann, A. S. Urban, J. Day, S. Lal, P. Nordlander, N. J. Halas,\nACSNano 2013,7,42.\n[13] J.G.Smith,J.A.Faucheaux,P.K.Jain, NanoToday 2015,10,67.\n[14] L. Zhou, Y. Tan, J. Wang, W. Xu, Y. Yuan, W. Cai, S. Zhu, J. Zhu, Nat.\nPhotonics2016,10,393.\n[15] S.Linic,P.Christopher,D.B.Ingram, Nat.Mater. 2011,10,911.\n[16] Z. Zheng, W. Xie, B. Huang, Y. Dai, Chem., A Eur. J. 2018,24,\n18322.\n[17] P. R. West, S. Ishii, G. V. Naik, N. K. Emani, V. M. Shalaev, A.\nBoltasseva, LaserPhoton.Rev. 2010,4,795.\n[18] G.V.Naik,V.M.Shalaev,A.Boltasseva, Adv.Mater. 2013,25,3264.\n[19] W.A.Murray,W.L.Barnes, Adv.Mater. 2007,19,3771.\n[20] Y.Cui,A.Lauchner,A.Manjavacas,F.J.GarcíaDeAbajo,N.J.Halas,\nP.Nordlander, NanoLett. 2016,16,6390.\n[21] A.Lauchner,A.E.Schlather,A.Manjavacas,Y.Cui,M.J.Mcclain,G.\nJ. Stec, F. J. García De Abajo, P. Nordlander, N. J. Halas, Nano Lett.\n2015,15,6208.\n[22] T.-C.Hung,B.Kiraly,J.H.Strik,A.A.Khajetoorians,D.Wegner, Nano\nLett.20",
            "page": 11
        },
        "id": "4134"
    },
    {
        "document": "A.Manjavacas",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4211"
    },
    {
        "document": "A.Santos",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4218"
    },
    {
        "document": "L.B.Alemany",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4228"
    },
    {
        "document": "A.L.Santos",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4232"
    },
    {
        "document": "L.B.Alemany",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4241"
    },
    {
        "document": "A.L.Santos",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4253"
    }
]